Methods for the diagnosis of lung cancer
AssigneesFundacio Privada Institut d'Investigacio Oncologica de Vall Hebron, Institució Catalana De Recerca↑Estudis AvançAts, Peptomyc, S.L.
InventorsLaura SOUCEK, Marie-Eve BEAULIEU
Life of this patent
Estimating the term…
Abstract
The invention relates to the diagnostic uses of a conjugate comprising Omomyc or a functionally equivalent variant thereof and a detectable label for detecting lung cancer by pulmonary administration of the conjugate. The invention also relates to a method for detecting or imaging lung cancer using said conjugates, kits comprising said conjugates and conjugates comprising a contrast agent or an imaging agent.
Claims21
1-23. (canceled)
A method for detecting or imaging lung cancer cells in a subject comprising:
- i) administering by a pulmonary route a conjugate comprising a polypeptide comprising the sequence SEQ ID NO:
- 1 or a functionally equivalent variant thereof, and a detectable label;
- ii) waiting a sufficient time to allow for the conjugate to enter into the proliferating lung cells;
- and
- iii) detecting the proliferating lung cells by applying an imaging technique to the subject to detect the site of accumulation of the conjugate in the subject, thereby detecting or imaging the site of proliferation.
Kit for the diagnosis of lung cancer comprising:
- (i) a conjugate comprising a polypeptide comprising the sequence SEQ ID NO:
- 1 or a functionally equivalent variant thereof, and a detectable label;
- (ii) a device for the pulmonary administration of the conjugate of item (i);
- and
- (iii) means for packaging items (i) and (ii).
A conjugate comprising:
- i) a polypeptide comprising the sequence SEQ ID NO:
- 1 or a functionally equivalent variant thereof, and
- ii) a detectable label selected from the group consisting of a contrast agent or an imaging agent.
Dependencies are inferred from the claim text.